CDK1 and cancer: Compared with the resistant cases (Fig. 4b), the sensitive cases presented a significantly lower proportion of cancer cells expressing CDK1 (P = 0.019) and a trend toward a greater proportion of cancer cells expressing MMP7 (P = 0.067).